About Essenlix
Essenlix is a Healthcare company based in Monmouth Junction (United States) founded in 2013. Mobile health self-test platform is provided using nanotechnology and AI. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Essenlix has raised $20 million across 1 funding round from investors including Carret Private and Quadrant. Essenlix offers products and services including iMOST-L, Q-Card, and iMOST Dock. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is Essenlix Corporation. Its competitors include iHealth Labs, Masimo and Levels; 2 of its 3 listed competitors have raised funding.
Company details
Essenlix is engaged in transforming health diagnostics through its innovative iMOST platform. The company operates in the healthcare sector, specializing in medical devices for personal and clinical use. Solutions are developed using nanotechnology, advanced imaging, and artificial intelligence to enable instant mobile self-testing. Tests for various biomarkers in body fluids like blood and saliva are provided, delivering lab-quality results quickly. The platform is designed to be user-friendly, cost-effective, and accessible, supporting digital health monitoring worldwide.
- Headquarters Monmouth Junction, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website essenlix.com
- Social LinkedIn
- Legal Name Essenlix Corporation
- Total Equity Funding$20M (USD)
in 1 rounds
- Latest Funding Round$20M (USD), Series A
Aug 2018
- InvestorsCarret Private
& 1 more
Products & Services of Essenlix
Essenlix offers a comprehensive portfolio of products and services, including iMOST-L, Q-Card, and iMOST Dock.
Automated device for HGB, WBC, and 5-DIFF analysis.
Single-use biochip with reagents for iMOST analyzer.
Supportive dock for iMOST platform testing operations.
Funding Insights of Essenlix
Essenlix has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 1
- Last Round Series A — $20M
- First Round $20M
(Aug 2018)
- Investors Count 2
All 1 funding rounds of Essenlix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $20M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Essenlix
Essenlix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Carret Private and Quadrant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Quadrant Management is engaged in private equity investments. | 1970 | quadrantmgt.com | New York, United States | |
Multi-family office services are provided to high net worth families. | 2016 | carretprivate.com | Wan Chai, China |
Investor details for Essenlix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Essenlix
2 people are tracked at Essenlix (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Wu Chou | Chief Software Officer | Leadership |
Mingquan Wu | Principal Engineer | Team |
Complete people profiles for Essenlix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Essenlix
2 dated milestones of Essenlix across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Essenlix is founded.
- Funding First funding round of $20.0M.
Competitors of Essenlix
Essenlix has 3 listed competitors in our database, 2 of them funded. They include iHealth Labs, Masimo and Levels.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ihealthlabs.com | 2010 | Mountain View, United States | $25M | 104 | Personal healthcare devices for vital monitoring are designed and produced. | |
| masimo.com | 1989 | Irvine, United States | 24 | Provider of wide range of devices to monitor health parameters | ||
| levels.com | 2019 | United States | $67M | 35 | Wearable devices for metabolic health insights are provided. |
Detailed competitors of Essenlix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Essenlix (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Essenlix
Complete news archive for Essenlix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Essenlix
Essenlix was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Essenlix is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
Essenlix is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series A of $20M, raised on Aug 2018.
Essenlix is engaged in transforming health diagnostics through its innovative iMOST platform. The company operates in the healthcare sector, specializing in medical devices for personal and clinical use. Solutions are developed using nanotechnology, advanced imaging, and artificial intelligence to enable instant mobile self-testing. Tests for various biomarkers in body fluids like blood and saliva are provided, delivering lab-quality results quickly. The platform is designed to be user-friendly, cost-effective, and accessible, supporting digital health monitoring worldwide.
Essenlix's top competitors include iHealth Labs, Levels and Masimo.
Essenlix offers iMOST-L, Q-Card, and iMOST Dock.
Essenlix has 2 investors. Key investors include Carret Private, and Quadrant.
Essenlix operates through Essenlix Corporation.